Statistiche di base
| CIK | 1738906 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to 111, Inc. - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| August 29, 2025 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F, as amended by Amendment No. 1 thereto, of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make t |
|
| August 29, 2025 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on April 29, 2025, as amended by Amendment No. 1 thereto (the “Report”), I, Junling Liu, acting in the capacity |
|
| August 29, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A (Amendment No. 1) (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SEC |
|
| August 29, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement No. 333-229313 on Form S-8 of our report dated May 14, 2024, relating to the financial statements of 111, Inc., appearing in the Annual Report on Form 20-F/A of 111, Inc. for the year ended December 31, 2024. /s/ Deloitte Touche Tohmatsu Certified Public |
|
| August 29, 2025 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F, as amended by Amendment No. 1 thereto, of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make t |
|
| August 29, 2025 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on April 29, 2025, as amended by Amendment No. 1 thereto (the “Report”), I, Junling Liu, Chief Executive Office |
|
| June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by ch |
|
| June 20, 2025 |
111, Inc. Announces First Quarter 2025 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces First Quarter 2025 Unaudited Financial Results · Maintained Quarterly Operational Profitability · Operating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoY · Maintained Quarterly Positive Operating Cash Flow SHANGHAI, June 19, 2025 /PRNewswire/ – 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company c |
|
| April 29, 2025 |
Exhibit 15.3 中国北京建国门外大街1号国贸写字楼2座12-14层100004 12-14th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: [email protected] 网址 Web: www.tongshang.com April 29, 2025 111, Inc. 3-4/F, No. 295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear Sirs, We consent to the reference |
|
| April 29, 2025 |
Exhibit 11.2 111, INC. STATEMENT OF POLICIES GOVERNING MATERIAL NON-PUBLIC INFORMATION AND THE PREVENTION OF INSIDER TRADING (Adopted by the Board of Directors of 111, Inc. on AUGUST 21, 2018, effective upon the effectiveness of its registration statement on Form F-1 relating to its initial public offering) This Statement of Policies Governing Material Non-Public Information and the Prevention of |
|
| April 29, 2025 |
Exhibit 15.1 Our ref KKZ/742474-000001/28733992v1 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China 29 April 2025 Dear Sir and/or Madam 111, Inc. We have acted as legal advisers as to the laws of the Cayman Islands to 111, Inc., an exempted limited liability company incorporated in the Cayman Islands (the “Company”), in connection with the fil |
|
| April 29, 2025 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, Chief Executive Officer of the Company, certify, pursuant to |
|
| April 29, 2025 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, acting in the capacity of Chief Financial Officer of the Com |
|
| April 29, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement No. 333-229313 on Form S-8 of our report dated May 14, 2024, relating to the financial statements of 111, Inc., appearing in the Annual Report on Form 20-F of 111, Inc. for the year ended December 31, 2024. /s/ Deloitte Touche Tohmatsu Certified Public A |
|
| April 29, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated April 29, 2025, with respect to the consolidated financial statements included in the Annual Report of 111, Inc. on Form 20-F for the year ended December 31, 2024. We consent to the incorporation by reference of said report in the Registration Statements of 111, Inc. on Form S-8 No 333-229313. /s/ |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| April 29, 2025 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 29, 2025 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 29, 2025 |
Exhibit 2.4 Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”) American Depositary Shares (“ADSs”) each representing twenty Class A ordinary shares of 111, Inc., (the “we,” “our,” “our company,” or “us”) are listed and traded on the Nasdaq Global Market and, in connection with this listing (but not for trading), |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by c |
|
| March 20, 2025 |
111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results Exhibit 99.1 111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results • Achieved First-Ever Annual Operating Profit • Bottom Line Improved by RMB332.7 Million YoY in 2024 • Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 • Q4’24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoY • Achieved First-Ever Annual Positive |
|
| February 11, 2025 |
111, Inc. Regains Compliance with NASDAQ Requirement Exhibit 99.1 111, Inc. Regains Compliance with NASDAQ Requirement SHANGHAI, February 11, 2025 /PRNewswire/ – 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq S |
|
| February 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| January 8, 2025 |
111, Inc. Announces ADS Ratio Change Exhibit 99.1 111, Inc. Announces ADS Ratio Change SHANGHAI, January 8, 2025 /PRNewswire/ - 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it plans to change the ratio of its American Depositary Shares ( |
|
| January 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by |
|
| November 27, 2024 |
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Third Quarter 2024 Unaudited Financial Results · Maintained Operational Profitability for the Third Consecutive Quarter · Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY · Held Positive Operating Cash Flow for Three Consecutive Quarters SHANGHAI, November 27, 2024 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leadin |
|
| November 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| November 4, 2024 |
111, Inc. Announces Change to Board of Directors Exhibit 99.1 111, Inc. Announces Change to Board of Directors SHANGHAI, November 4, 2024 /PRNewswire/ - 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that Dr. Leon Lian Yong Chen has tendered his resignatio |
|
| August 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by |
|
| August 29, 2024 |
111, Inc. Announces Second Quarter 2024 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Second Quarter 2024 Unaudited Financial Results • Maintained Operational Profitability for the Second Consecutive Quarter • Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY • Held Positive Operating Cash Flow for Two Consecutive Quarters SHANGHAI, August 29, 2024 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading |
|
| July 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN -PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indic |
|
| July 19, 2024 |
Exhibit 16.1 Deloitte Touche Tohmatsu Certified Public Accountants LLP 30/F Bund Center 222 Yan An Road East Shanghai 200002, PRC Tel: +86 21 6141 8888 Fax: +86 21 6335 0003 www.deloitte.com/cn July 19, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read 111, Inc.’s Form 6-K dated July 19, 2024, and have the following comments: 1. W |
|
| May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by che |
|
| May 23, 2024 |
111, Inc. Announces First Quarter 2024 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces First Quarter 2024 Unaudited Financial Results • Turned to Quarterly Operational Profitability for the First Time • Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% • Achieved Positive Operating Cash Flow SHANGHAI, May 23, 2024 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare plat |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| May 14, 2024 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| May 14, 2024 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, acting in the capacity of Chief Financial Officer of the Com |
|
| May 14, 2024 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| May 14, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-229313 on Form S-8 of our reports dated May 14, 2024, relating to the financial statements of 111, Inc. and the effectiveness of 111, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 20-F for the year ended Dece |
|
| May 14, 2024 |
Exhibit 15.3 中国北京建国门外大街1号国贸写字楼2座12-14层100004 12-14th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: [email protected] 网址 Web: www.tongshang.com May 14, 2024 111, Inc. 3-4/F, No. 295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear Sirs, We consent to the reference to |
|
| May 14, 2024 |
Exhibit 15.1 Our refKKZ/742474-000001/28733992v1 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China May 9, 2024 Dear Sir and/or Madam 111, Inc. We have acted as legal advisers as to the laws of the Cayman Islands to 111, Inc., an exempted limited liability company incorporated in the Cayman Islands (the “Company”), in connection with the filing |
|
| May 14, 2024 |
111, Inc. COMPENSATION RECOUPMENT POLICY Exhibit 97 111, Inc. COMPENSATION RECOUPMENT POLICY This 111, Inc. Compensation Recoupment Policy (the “Policy”) has been adopted by the Board of Directors (the “Board”) of 111, Inc. (the “Company”) on September 7, 2023. This Policy provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting |
|
| May 14, 2024 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, Chief Executive Officer of the Company, certify, pursuant to |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Checkone): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Per |
|
| March 21, 2024 |
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results Exhibit 99.1 111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results SHANGHAI, March 21, 2024 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal |
|
| March 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by c |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| February 27, 2024 |
111 Announces Receipt of Withdrawal of Going Private Proposal Exhibit 99.1 111 Announces Receipt of Withdrawal of Going Private Proposal 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it has received a notice dated Feburary 27, 2024 on behalf of the consortium comprising Dr. Gang Yu, co-founder a |
|
| February 27, 2024 |
EX-99.24 3 tm245448d1ex99-24.htm EXHIBIT 99.24 Exhibit 99.24 TERMINATION AGREEMENT THIS TERMINATION AGREEMENT, dated as of February 27, 2024 (this “Agreement”), is made by and among: A. Dr. Gang Yu, a U.S. citizen and the co-founder and co-chairman of the Company (as defined below), B. Mr. Junling Liu, an Australian citizen and the co-founder, co-chairman and chief executive officer of the Company |
|
| February 27, 2024 |
EX-99.3 2 tm245448d1ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 Termination Agreement This Termination Agreement (“Termination Agreement”) is made and entered into dated February 27, 2024, by and among each undersigned. Reference is hereby made to the Statement of Beneficial Ownership on Schedule 13D filed with the Securities and Exchange Commission by the Parties (as amended to date, the “Schedule 13D”) |
|
| February 27, 2024 |
YI / 111, Inc. - Depositary Receipt (Common Stock) / Gang Yu - SC 13D/A Activist Investment SC 13D/A 1 tm245448d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* 111, INC. (Name of Issuer) Class A ordinary shares, $0.00005 par value per share Class B ordinary shares, $0.00005 par value per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) Gang Yu Xiaomei M |
|
| November 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| November 30, 2023 |
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Third Quarter 2023 Unaudited Financial Results SHANGHAI, November 30, 2023 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September |
|
| August 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by |
|
| August 24, 2023 |
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results 111, Inc. Announces Second Quarter 2023 Unaudited Financial Results SHANGHAI, August 24, 2023 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2023. Second Q |
|
| August 1, 2023 |
August 1, 2023 Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: 111, Inc. Annual Report on Form 20-F Response Dated September 27, 2022 File No. 001-38639 Attn: Division of Corporation Finance Office of Trade & Services VIA EDGAR Dear Kyle Wiley and Jennifer Thompson: This letter sets forth the responses of 111, Inc. (the “Company”) t |
|
| July 17, 2023 |
Exhibit 99.19 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on July 17, 2023 BY: Vendavel Investment SPC acting on behalf of Global Opportunity Fund SP, a segregated portfolio formed by Vendavel Investment SPC, a segregated portfolio company existing under the laws of the Cayman Islands with its registered address at Fifth Floor, Zephyr House22 Mary Street, George Town, P. |
|
| July 17, 2023 |
YI / 111 Inc - ADR / Gang Yu - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* 111, INC. (Name of Issuer) Class A ordinary shares, $0.00005 par value per share Class B ordinary shares, $0.00005 par value per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) Gang Yu Xiaomei Michelle Song Infinity Cosmo Limited Junli |
|
| July 17, 2023 |
Exhibit 99.3 JOINT FILING AGREEMENT In accordance with Rule 13d-(k)(l) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree (i) to the joint filing, on behalf of each of them, of a statement on Schedule 13D (including amendments thereto) with respect to the shares of 111, Inc., an exempted company with limited liability registered under the laws of the Ca |
|
| July 17, 2023 |
Exhibit 99.20 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on July 17, 2023 BY: Hangzhou Huazhi Capital lnvestment Management Co., Ltd., a limited liability company organized and existing under the laws of People’s Republic of China with its registered address at Room 528, No.88，Yuan Shuai Miao Hou, Shangcheng District, Hangzhou City, Zhejiang Province, China (the “Additi |
|
| July 17, 2023 |
Exhibit 99.22 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on July 17, 2023 BY: SAIF Partners (Nanjing) Equity Investment Fund (LP), a limited partnership organized and existing under the laws of People’s Republic of China with its registered address at Wei Ke Space C28, Yangzijiang New Financial Creative Block, No. 396 Binjiang Avenue, Nanjing Area, China (Jiangsu) Pilot |
|
| July 17, 2023 |
Exhibit 99.17 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on July 17, 2023 BY: ALLIED CHINA INVESTMENT LIMITED, a limited liability company organized and existing under the laws of Hong Kong SAR with its registered address at Unit 2308, 23/F, Tower A Pingan IFC, 01-03 Xinyuannanlu, Chaoyang District, Beijing 100027, China (the “Additional Member”). RECITALS: (A) |
|
| July 17, 2023 |
Exhibit 99.23 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on July 17, 2023 BY: SAIF Partners (Nanjing) Hengzhun Venture Capital Fund (LP), a limited partnership organized and existing under the laws of People’s Republic of China with its registered address at No. 2-3, Zidong Road, Maqun Street, Qixia District, Nanjing (the “Additional Member”). RECITALS: (A) On July 17, |
|
| July 17, 2023 |
Exhibit 99.21 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on July 17, 2023 BY: Suzhou Kunjie Venture Capital Partnership (Limited Partnership), a limited partnership organized and existing under the laws of People’s Republic of China with its registered address at Building 38, Suzhou Bay Oriental Venture Capital Base, No. 333 Yingbin Avenue, Wujiang District, Suzhou (the |
|
| July 17, 2023 |
AMENDED AND RESTATED CONSORTIUM AGREEMENT Exhibit 99.16 AMENDED AND RESTATED CONSORTIUM AGREEMENT THIS AMENDED AND RESTATED CONSORTIUM AGREEMENT, dated as of July 17, 2023 (this “Agreement”, including all schedules annexed hereto, as hereafter from time to time amended, modified, supplemented, renewed or replaced), is made by and among: A. Dr. Gang Yu, a U.S. citizen and the co-founder and co-chairman of the Company (“Dr. Yu”), B. Mr. Jun |
|
| July 17, 2023 |
Exhibit 99.18 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on July 17, 2023 BY: Shanghai Youwei Genilink Capital Management Limited, a limited liability company organized and existing under the laws of People’s Republic of China with its registered address at 4th Floor, No. 391-393(Odd Number), Dongdaming Road, Hongkou District, Shanghai (Centralized registration Place) ( |
|
| June 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by ch |
|
| June 15, 2023 |
111, Inc. Announces First Quarter 2023 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces First Quarter 2023 Unaudited Financial Results SHANGHAI, June 15, 2023 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2023 |
|
| April 28, 2023 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 28, 2023 |
Exhibit 16.1 April 28, 2023 VIA EDGAR Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: 111, Inc. Submission under the Item 16I(a) of Form 20-F Attn: Division of Corporation Finance Office of Life Sciences Dear Sir/Madam, In compliance with the Holding Foreign Companies Accountable Act, 111, Inc. (the “Company”) is submitting via EDGA |
|
| April 28, 2023 |
Exhibit 15.3 中国北京建国门外大街1号国贸写字楼2座12-14层100004 12-14th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: [email protected] 网址 Web: www.tongshang.com April 28, 2023 111, Inc. 3-5/F, No. 295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear Sirs, We consent to the reference |
|
| April 28, 2023 |
Exhibit 15.1 Our refKKZ/742474-000001/25878602v2 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China April 28, 2023 Dear Sir and/or Madam 111, Inc. We have acted as legal advisers as to the laws of the Cayman Islands to 111, Inc., an exempted limited liability company incorporated in the Cayman Islands (the “Company”), in connection with the fil |
|
| April 28, 2023 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, Chief Executive Officer of the Company, certify, pursuant to |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| April 28, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-229313 on Form S-8 of our reports dated April 28, 2023, relating to the financial statements of 111, Inc. and the effectiveness of 111, Inc.’s internal control over financial reporting which appear in 111, Inc.’s Annual Report on Form 20-F for the yea |
|
| April 28, 2023 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 28, 2023 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, acting in the capacity of Chief Financial Officer of the Com |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate by c |
|
| March 23, 2023 |
111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results Exhibit 99.1 111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results SHANGHAI, March 23, 2023 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal |
|
| January 31, 2023 |
CORRESP 1 filename1.htm January 31, 2023 Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: 111, Inc. Annual Report on Form 20-F Response Dated September 27, 2022 File No. 001-38639 Attn: Division of Corporation Finance Office of Trade & Services VIA EDGAR Dear Jennie Beysolow and Erin Jaskot: This letter sets forth the responses of 11 |
|
| December 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate b |
|
| December 1, 2022 |
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Third Quarter 2022 Unaudited Financial Results SHANGHAI, December 1, 2022 /PRNewswire/ ? 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 3 |
|
| October 31, 2022 |
Exhibit 99.9: Deed of Adherence by Tongyi Investment Holdings Limited, dated October 29, 2022 Exhibit 99.9 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: Tongyi Investment Holdings Limited, a limited liability company organized and existing under the laws of Cayman with its registered address at Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (the “Additional Mem |
|
| October 31, 2022 |
Exhibit 99.8 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: Zall Capital Limited, a limited liability company organized and existing under the laws of British Virgin Islands with its registered address at OMC Chambers, Wickhams Cay 1, Road Town, Tortola, British Virgin Islands (the “Additional Member”). RECITALS: (A) On September 9, 2022, the parties |
|
| October 31, 2022 |
Exhibit 99.7: Deed of Adherence by ClearVue Partners, L.P., dated October 29, 2022 Exhibit 99.7 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: ClearVue Partners, L.P., an exempted limited partnership organized and existing under the laws of Cayman Islands with its registered address at 4th Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, Cayman Islands (the “Additional Member”). RECITALS: (A) On |
|
| October 31, 2022 |
Exhibit 99.3: Joint Filing Agreement among the Reporting Persons, dated October 31, 2022 Exhibit 99.3 JOINT FILING AGREEMENT In accordance with Rule 13d-(k)(l) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree (i) to the joint filing, on behalf of each of them, of a statement on Schedule 13D (including amendments thereto) with respect to the shares of 111, Inc., an exempted company with limited liability registered under the laws of the Ca |
|
| October 31, 2022 |
Exhibit 99.12 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: Morning Star Resources Limited, a limited liability company organized and existing under the laws of British Virgin Islands, with its registered address at Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands (the “Additional Member”). RECITALS: (A) On September 9, 2022, the |
|
| October 31, 2022 |
Exhibit 99.6: Deed of Adherence by ClearVue YW Holdings, Ltd., dated October 29, 2022 Exhibit 99.6 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: ClearVue YW Holdings, Ltd., an exempted company organized and existing under the laws of Cayman Islands with its registered address at 4th Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, Cayman Islands (the “Additional Member”). RECITALS: (A) On Septembe |
|
| October 31, 2022 |
Exhibit 99.5: Deed of Adherence by 6 Dimensions Affiliates Fund, L.P., dated October 29, 2022 Exhibit 99.5 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: 6 Dimensions Affiliates Fund, L.P., an exempted limited partnership organized and existing under the laws of Cayman Islands with its registered address at c/o Maples Corporate Services Limited of PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (the “Additional Member”). RECI |
|
| October 31, 2022 |
Exhibit 99.15 October 29, 2022 The Special Committee of Board of Directors (the “Special Committee”) 111, Inc. (the “Company”) 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear members of the Special Committee: Reference is made to the preliminary non-binding proposal (the “Original Proposal”), dated as of September 9, 2022, from Dr. Gang Yu, co-fo |
|
| October 31, 2022 |
Exhibit 99.11 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: J.P. Morgan Trust Company of Delaware, a corporation incorporated under the laws of Delaware as the trustee for and on behalf of Hodge Mountain 2020 Irrevocable Trust (the “Additional Member”). RECITALS: (A) On September 9, 2022, the parties listed on Annex A to this Deed (the “Existing Mem |
|
| October 31, 2022 |
Exhibit 99.14 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: Ningbo Youkai Venture Capital Partnership (Limited Partnership), a limited partnership organized and existing under the laws of People’s Republic of China with its registered address at Room 109, Building 13, Zhihuijiayuan, Xiangbao Cooperation Zone, Ningbo, Zhejiang Province, China (the “A |
|
| October 31, 2022 |
Exhibit 99.10: Deed of Adherence by First Pharmacia International, dated October 29, 2022 Exhibit 99.10 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: First Pharmacia International, a limited liability company organized and existing under the laws of Cayman Islands with its registered address at Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (the “Additional Member”). RECITALS: (A) On Septe |
|
| October 31, 2022 |
Exhibit 99.13 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: Shanghai Changfeng Huixin Equity Investment Fund Management Co., Ltd., a limited liability company organized and existing under the laws of People’s Republic of China with its registered address at Room 304, 305, Building 248, 345 Yunling East Road, Putuo District, Shanghai, PRC (the “Addit |
|
| October 31, 2022 |
Exhibit 99.4 DEED OF ADHERENCE This Deed of Adherence (this “Deed”) is entered into on October 29, 2022 BY: 6 Dimensions Capital, L.P., an exempted limited partnership organized and existing under the laws of Cayman Islands with its registered address at c/o Maples Corporate Services Limited of PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (the “Additional Member”). RECITALS: (A |
|
| October 31, 2022 |
YI / 111, Inc. / Gang Yu - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* 111, INC. (Name of Issuer) Class A ordinary shares, $0.00005 par value per share Class B ordinary shares, $0.00005 par value per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) Gang Yu Xiaomei Michelle Song Infinity Cosmo Limited Junli |
|
| September 27, 2022 |
Division of Corporation Finance CORRESP 1 filename1.htm September 27, 2022 Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: 111, Inc. Annual Report on Form 20-F Filed April 29, 2022 File No. 001-38639 Attn: Division of Corporation Finance Office of Trade & Services VIA EDGAR Dear Jennie Beysolow and Erin Jaskot: This letter sets forth the responses of 111, Inc. (“1 |
|
| September 23, 2022 |
CORRESP 1 filename1.htm September 23, 2022 Ms. Jennie Beysolow Ms. Erin Jaskot Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4628 Washington, D.C. 20549 U.S.A. Re: 111, Inc. Form 20-F for Fiscal Year Ended December 31, 2021 Filed April 29, 2022 Dear Jennie Beysolow and Erin Jaskot: 111, Inc. (the “Company”) acknowledges receipt of a comment letter |
|
| September 23, 2022 |
EXHIBIT 99.1 111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee SHANGHAI, September 23, 2022 /PRNewswire/ - 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the ?Special Committee?), consisting of three independent directors, Mr. Jian Su |
|
| September 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate |
|
| September 9, 2022 |
EXHIBIT 99.1 111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company SHANGHAI, September 9, 2022 /PRNewswire/ - 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding proposal letter (the "Proposal") dated |
|
| September 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate |
|
| September 9, 2022 |
Exhibit 99.1 Execution Version CONSORTIUM AGREEMENT THIS CONSORTIUM AGREEMENT, dated as of September 9, 2022 (this ?Agreement?), is made by and among A. Dr. Gang Yu, a U.S. citizen and the co-founder and co-chairman of the Company (?Dr. Yu?), B. Mr. Junling Liu, an Australian citizen and the co-founder, co-chairman and chief executive officer of the Company (?Mr. Liu?, and together with Dr. Yu, th |
|
| September 9, 2022 |
Exhibit 99.3 JOINT FILING AGREEMENT In accordance with Rule 13d-(k)(l) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree (i) to the joint filing, on behalf of each of them, of a statement on Schedule 13D (including amendments thereto) with respect to the shares of 111, Inc., an exempted company with limited liability registered under the laws of the Ca |
|
| September 9, 2022 |
EX-99.2 3 dp180155ex9902.htm EXHIBIT 99.2 EXHIBIT 99.2 September 9, 2022 Board of Directors (the “Board”) 111, Inc. (the “Company”) 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear Members of the Board: We, Dr. Gang Yu, co-founder and co-chairman of the Company, Mr. Junling Liu, co- founder, co-chairman and chief executive officer of the Company ( |
|
| September 9, 2022 |
YI / 111, Inc. / Gang Yu - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 111, INC. (Name of Issuer) Class A ordinary shares, $0.00005 par value per share Class B ordinary shares, $0.00005 par value per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) Gang Yu Xiaomei Michelle Song Infinity Cosmo Limited Junling Liu Sunny Bay Glob |
|
| September 9, 2022 |
Exhibit 99.2 September 9, 2022 Board of Directors (the ?Board?) 111, Inc. (the ?Company?) 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China Dear Members of the Board: We, Dr. Gang Yu, co-founder and co-chairman of the Company, Mr. Junling Liu, co-founder, co-chairman and chief executive officer of the Company (collectively, the ?Co-Founders?) and Shangh |
|
| August 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by |
|
| August 25, 2022 |
111, Inc. Announces Second Quarter 2022 Unaudited Financial Results EX-99.1 2 dp179136ex9901.htm EXHIBIT 99.1 EXHIBIT 99.1 111, Inc. Announces Second Quarter 2022 Unaudited Financial Results SHANGHAI, August 25, 2022 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial resul |
|
| June 16, 2022 |
111, Inc. Announces First Quarter 2022 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces First Quarter 2022 Unaudited Financial Results SHANGHAI, June 16, 2022 /PRNewswire/ ? 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2022 |
|
| June 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by ch |
|
| May 5, 2022 |
111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act Exhibit 99.1 111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act SHANGHAI, May 5, 2022 /PRNewswire/ - 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that on May 4th, 2022, the Securities and Exchange Commission (the "SEC") provisionally listed the Company as a "Commission-Identif |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by che |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
| April 29, 2022 |
Consent of Maples and Calder (Hong Kong) LLP Exhibit 15.1 Our refKKZ/742474-000001/19339623v1 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China April 29, 2022 Dear Sir and/or Madam 111, Inc. We have acted as legal advisers as to the laws of the Cayman Islands to 111, Inc., an exempted limited liability company incorporated in the Cayman Islands (the “Company”), in connection with the fil |
|
| April 29, 2022 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, Chief Executive Officer of the Company, certify, pursuant to |
|
| April 29, 2022 |
Consent of Deloitte Touche Tohmatsu Certified Public Accountants LLP Exhibit 15.2 ? ? CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ? ? We consent to the incorporation by reference in Registration Statement No. 333-229313 on Form S-8 of our reports dated April 29, 2022, relating to the financial statements of 111, Inc. and the effectiveness of 111, Inc.?s internal control over financial reporting appearing in this Annual Report on Form 20-F for the year |
|
| April 29, 2022 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 29, 2022 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, acting in the capacity of Chief Financial Officer of the Com |
|
| April 29, 2022 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| March 17, 2022 |
111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results Exhibit 99.1 111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results SHANGHAI, March 17, 2022 /PRNewswire/ ? 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by c |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by c |
|
| February 10, 2022 |
YI / 111, Inc. / ClearVue Partners, L.P. - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* 111, Inc.** (Name of Issuer) Class A Ordinary Shares, par value US$0.00005 per share (Title of Class of Securities) 68247Q102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate b |
|
| November 19, 2021 |
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Third Quarter 2021 Unaudited Financial Results SHANGHAI, November 19, 2021 /PRNewswire/ ? 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September |
|
| September 7, 2021 |
6-K 1 dp1575156k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principa |
|
| September 7, 2021 |
111 Inc. Announces $10 Million Share Repurchase Program EX-99.1 2 dp157515ex9901.htm EXHIBIT 99.1 Exhibit 99.1 111 Inc. Announces $10 Million Share Repurchase Program SHANGHAI, Sept.7, 2021 /PRNewswire/ - 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that its board of directors (the "Board") ha |
|
| August 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by |
|
| August 27, 2021 |
111, Inc. Announces Second Quarter 2021 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Second Quarter 2021 Unaudited Financial Results SHANGHAI, August 27, 2021 /PRNewswire/ ? 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2 |
|
| May 27, 2021 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned a |
|
| May 27, 2021 |
YI / 111, Inc. / Verlinvest Asia (HK) Ltd - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* 111, Inc. (Name of Issuer) Common Stock, par value of $0.00005 per share (Title of Class of Securities) 68247Q102** (CUSIP Number) March 2, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| May 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by che |
|
| May 19, 2021 |
111, Inc. Announces First Quarter 2021 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces First Quarter 2021 Unaudited Financial Results SHANGHAI, May 19, 2021 /PRNewswire/ ? 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2021. |
|
| April 30, 2021 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 30, 2021 |
Consent of Maples and Calder (Hong Kong) LLP Exhibit 15.2 Our ref KKZ/742474-000001/19339623v1 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China 30 April 2021 Dear Sir and/or Madam 111, Inc. We have acted as legal advisers as to the laws of the Cayman Islands to 111, Inc., an exempted limited liability company incorporated in the Cayman Islands (the “Company”), in connection with the fil |
|
| April 30, 2021 |
Exhibit 4.27 Supplementary Agreement of Capital Increase Agreement in respect of Yao Fang Information Technology (Shanghai) Co., Ltd. ? Dated August 26, 2020 ? 1 This Supplementary Agreement of Capital Increase Agreement in respect of Yao Fang Information Technology (Shanghai) Co., Ltd. (this ?Supplementary Agreement?) is made in Shanghai as of August 26, 2020 by and among: A. Yao Fang Information |
|
| April 30, 2021 |
Consent of Deloitte Touche Tohmatsu Certified Public Accountants LLP EX-15.3 12 yi-20201231xex15d3.htm EXHIBIT 15.3 Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-229313 on Form S-8 of our reports dated April 29, 2021, relating to the financial statements of 111, Inc. and the effectiveness of 111, Inc.’s internal control over financial reporting, appearing in this |
|
| April 30, 2021 |
Consent of Commerce & Finance Law Offices EX-15.1 10 yi-20201231xex15d1.htm EXHIBIT 15.1 Exhibit 15.1 中国北京市建国门外大街甲12号新华保险大厦6层100022 6/F, NCI Tower, A12 Jianguomenwai Avenue, Beijing 100022, China 电话 Tel: +86 10 6569 3399 传真 Fax: +86 10 6569 3838 电邮 Email: [email protected] 网址 Web: www.tongshang.com April 30, 2021 111, Inc. 3-4/F, No. 295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear Sirs, We con |
|
| April 30, 2021 |
Exhibit 4.28 Capital Increase Agreement in respect of 1 Pharmacy Yao Fang Technology (Shanghai) Co., Ltd. Dated December 14, 2020 Table of Contents Section Page 1. Definitions and Interpretation 5 2. Capital Increase 7 3. Payment 7 4. Warranties and Covenants 9 5. Completion of the Capital Increase 10 6. Rights and Obligations of the Shareholders 11 7. Employee Incentive Plan 18 8. Admission of Ne |
|
| April 30, 2021 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1.I have reviewed this annual report on Form 20-F of 111, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 30, 2021 |
Table of Contents ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 30, 2021 |
EX-4.26 2 yi-20201231xex4d26.htm EXHIBIT 4.26 Exhibit 4.26 Capital Increase Agreement in respect of Yao Fang Information Technology (Shanghai) Co., Ltd. Dated August 10, 2020 Table of Contents Section Page 1. Definitions and Interpretation 2 2. Capital Increase 4 3. Payment 4 4. Warranties and Covenants 5 5. Completion of the Capital Increase 6 6. Rights and Obligations of the Shareholders 6 7. Em |
|
| April 30, 2021 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, acting in the capacity of Chief Financial Officer of the Com |
|
| April 30, 2021 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the ?Company?) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Junling Liu, Chief Executive Officer of the Company, certify, pursuant to |
|
| March 18, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2021 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China (Address of principal executive offices) Indicate by c |
|
| March 18, 2021 |
111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results SHANGHAI, March 18, 2021 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), "), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quart |
|
| February 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* 111, Inc. (Name of Issuer) Class A Ordinary Shares, par value US$0.00005 per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| December 22, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2020 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| December 22, 2020 |
Exhibit 99.1 111, Inc. Announces Additional Round of New Capital Injection Led by Esteemed List of Technology Investment Firms SHANGHAI, December 22, 2020 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced the successful completion of |
|
| November 19, 2020 |
111, Inc. Announces Third Quarter 2020 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Third Quarter 2020 Unaudited Financial Results SHANGHAI, November 19, 2020 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the third quarter ended September 30, 2020. Thi |
|
| November 19, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| November 6, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 Commission file number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indicate b |
|
| August 20, 2020 |
Exhibit 99.1 111, Inc. Announces New Capital Injection and Strategic Plan to Expand Access to China’s Capital Markets · Completion of new capital injection in principal subsidiary Yao Fang Shanghai · Initiation to list shares of principal subsidiary Yao Fang Shanghai on the STAR Market · 111 firmly committed to maintaining Nasdaq listing status SHANGHAI, August 20, 2020 /PRNewswire/ – 111, Inc. (" |
|
| August 20, 2020 |
111, Inc. Announces Second Quarter 2020 Unaudited Financial Results Exhibit 99.2 111, Inc. Announces Second Quarter 2020 Unaudited Financial Results SHANGHAI, August 20, 2020 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a company dedicated to digitally connecting patients with drugs and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Highlights · Net re |
|
| August 20, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2020 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) I |
|
| May 21, 2020 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2020 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indi |
|
| May 21, 2020 |
111, Inc. Announces First Quarter 2020 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces First Quarter 2020 Unaudited Financial Results SHANGHAI, May 21, 2020 (PR Newswire) – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2020. First Quarter 2020 Highlights (in comparis |
|
| April 16, 2020 |
Exhibit 4.23 Amended Exclusive Support Services Agreement Between GUANGDONG YIHAO PHARMACY CO., LTD. And YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. July 1, 2019 This Amended Exclusive Support Services Agreement (the “Agreement”) is concluded and signed on July 1, 2019 in Shanghai, the People’s Republic of China (“China”) by and between: GUANGDONG YIHAO PHARMACY CO., LTD. (the “Operator”) |
|
| April 16, 2020 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yang Chen, Chief Financial Officer of the Company, certify, pursuant to 1 |
|
| April 16, 2020 |
Exhibit 2.4 Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”) American Depositary Shares (“ADSs”) each representing two Class A ordinary shares of 111, Inc., (the “we,” “our,” “our company,” or “us”) are listed and traded on the Nasdaq Global Market and, in connection with this listing (but not for trading), th |
|
| April 16, 2020 |
Exhibit 4.25 Amended Exclusive Support Services Agreement Between SHANGHAI YAOWANG E-COMMERCE CO., LTD. And YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. July 1, 2019 This Amended Exclusive Support Services Agreement (the “Agreement”) is concluded and signed on July 1, 2019 in Shanghai, the People’s Republic of China (“China”) by and between: SHANGHAI YAOWANG E-COMMERCE CO., LTD. (the “Oper |
|
| April 16, 2020 |
Consent of Deloitte Touche Tohmatsu Certified Public Accountants LLP Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement No. 333-229313 on Form S-8 of our report dated April 16, 2020, relating to the financial statements of 111, Inc. appearing in this Annual Report on Form 20-F for the year ended December 31, 2019. /s/ Deloitte Touche Tohmatsu Certified Public Accountants L |
|
| April 16, 2020 |
Consent of Commerce & Finance Law Offices Exhibit 15.1 [Commerce & Finance Law Offices Letterhead] April 16, 2020 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear Sirs, We consent to the reference to our firm under the headings “Item 3. Key Information — D. Risk Factors,” and “Item 4. Information on the Company — C. Organizational Structure,” in 111, Inc.’s Annual Report on Form |
|
| April 16, 2020 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1. I have reviewed this annual report on Form 20-F of 111, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the ci |
|
| April 16, 2020 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of 111, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 16, 2020 |
Exhibit 4.24 Amended Exclusive Support Services Agreement Between GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO., LTD. And YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. July 1, 2019 This Amended Exclusive Support Services Agreement (the “Agreement”) is concluded and signed on July 1, 2019 in Shanghai, the People’s Republic of China (“China”) by and between: GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO |
|
| April 16, 2020 |
Consent of Maples and Calder (Hong Kong) LLP EX-15.2 12 a19-266481ex15d2.htm EX-15.2 Exhibit 15.2 [Maples and Calder (Hong Kong) LLP Letterhead] Our ref KKZ/742474-000001/16431314v1 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China 16 April 2020 Dear Sir and/or Madam 111, Inc. We have acted as legal advisers as to the laws of the Cayman Islands to 111, Inc., an exempted limited liability |
|
| April 16, 2020 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, Chief Executive Officer of the Company, certify, pursuant to |
|
| April 16, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 or x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019. or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) |
|
| March 13, 2020 |
YI / 111, Inc. 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2020 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) In |
|
| March 13, 2020 |
111, Inc. Announces Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results SHANGHAI, CHINA - March 12, 2020 - 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019. Fourth Quarter 2019 Highlights · Net |
|
| February 24, 2020 |
YI / 111, Inc. / Clearvue Partners, L.p. - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* 111, Inc. (Name of Issuer) Class A Ordinary Shares, par value US$0.00005 per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| January 29, 2020 |
SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* 111, Inc. (Name of Issuer) Class A ordinary shares, $0.00005 par value per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| January 29, 2020 |
EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the shares of Class A ordinary shares, par value of $0. |
|
| November 15, 2019 |
YI / 111, Inc. 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2019 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) |
|
| November 15, 2019 |
111, Inc. Announces Third Quarter 2019 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Third Quarter 2019 Unaudited Financial Results SHANGHAI, CHINA — November 14, 2019 - 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2019. Third Quarter 2019 Highlights · Net revenues were RMB1.11 billion ( |
|
| August 19, 2019 |
YI / 111, Inc. 6-K - Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2019 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) I |
|
| August 19, 2019 |
Exhibit 99.1 111, Inc. Announces Second Quarter 2019 Unaudited Financial Results and US$10 Million Share Repurchase Program SHANGHAI, Aug. 15, 2019 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2019 and US$10 million share rep |
|
| May 17, 2019 |
111 Announces Changes to its Board of Directors Exhibit 99.1 111 Announces Changes to its Board of Directors SHANGHAI, May 16, 2019 — 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform, today announced that Dr. Leon Lian Yong Chen has been appointed as a new member to the board of directors. Meanwhile, Mr. Harry Chi Hui will no longer serve as a director for personal reasons. Both change |
|
| May 17, 2019 |
YI / 111, Inc. 6-K Current Report of Foreign Issuer 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2019 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indi |
|
| May 16, 2019 |
111, Inc. Announces First Quarter 2019 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces First Quarter 2019 Unaudited Financial Results SHANGHAI, CHINA — May 16, 2019 - 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights · Net revenues were RMB655.6 million (US$97.7 |
|
| May 16, 2019 |
YI / 111, Inc. 6-K Current Report of Foreign Issuer 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2019 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) Indi |
|
| April 10, 2019 |
Consent of Commerce & Finance Law Offices Exhibit 15.1 [Commerce & Finance Law Offices Letterhead] April 10, 2019 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China Dear Sirs, We consent to the reference to our firm under the headings “Item 3. Key Information—D. Risk Factors,” and “Item 4. Information on the Company—C. Organizational Structure” in 111, Inc.’s Annual Report on Form 20-F |
|
| April 10, 2019 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Junling Liu, certify that: 1. I have reviewed this annual report on Form 20-F of 111, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the ci |
|
| April 10, 2019 |
Consent of Maples and Calder (Hong Kong) LLP Exhibit 15.2 [Maples and Calder (Hong Kong) LLP Letterhead] Our ref KKZ/742474-000001/14284628v2 111, Inc. 3-5/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China 10 April 2019 Dear Sirs 111, Inc. We have acted as legal advisers as to the laws of the Cayman Islands to 111, Inc., an exempted limited liability company incorporated in the Cayman Islands (the “Co |
|
| April 10, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 or x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018. or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) |
|
| April 10, 2019 |
Exhibit 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Junling Liu, Chief Executive Officer of the Company, certify, pursuant to |
|
| April 10, 2019 |
Exhibit 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of 111, Inc. (the “Company”) on Form 20-F for the year ended December 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yang Chen, Chief Financial Officer of the Company, certify, pursuant to 1 |
|
| April 10, 2019 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of 111, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circ |
|
| April 10, 2019 |
Consent of Deloitte Touche Tohmatsu Certified Public Accountants LLP Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-229313 on Form S-8 of our report dated April 9, 2019, relating to the consolidated financial statements and financial statement schedule of 111, Inc., its subsidiaries, variable interest entities (“VIEs”) and VIEs’ subsidiaries (collectively, the “Gro |
|
| March 8, 2019 |
111, Inc. Announces Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results SHANGHAI, CHINA - March 7, 2019 - 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2018. Fourth Quarter 2018 Highlights · Net r |
|
| March 8, 2019 |
YI / 111, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2019 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) In |
|
| February 27, 2019 |
111, Inc. Announces the Appointment of a New Chief Financial Officer EX-99.1 2 a19-55461ex99d1.htm EX-99.1 Exhibit 99.1 111, Inc. Announces the Appointment of a New Chief Financial Officer SHANGHAI, China, February 27, 2019 (GLOBE NEWSWIRE) - 111, Inc. (Nasdaq: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform, today announced that Mr. Yang Chen has been appointed as Chief Financial Officer, effective immediately on February |
|
| February 27, 2019 |
YI / 111, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2019 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) |
|
| February 14, 2019 |
EXHIBIT 99.1 Joint Filing Agreement Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this Exhibit is attached is filed on behalf of each of them. Each of them is individually eligible to use the Schedule 13G to which this Exhibit is attached. Each of them is responsible for the timely f |
|
| February 14, 2019 |
SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 111, INC. (Name of Issuer) Class A ordinary shares, par value $0.00005 per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 11, 2019 |
YI / 111, Inc. / Clearvue Partners, L.p. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* 111, Inc.** (Name of Issuer) Class A Ordinary Shares, par value US$0.00005 per share (Title of Class of Securities) 68247Q102 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| January 28, 2019 |
SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* 111, Inc. (Name of Issuer) Class A ordinary shares, $0.00005 par value per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| January 28, 2019 |
EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the shares of Class A ordinary shares, par value of $0. |
|
| January 28, 2019 |
SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* 111, Inc. (Name of Issuer) Class A ordinary shares, $0.00005 par value per share (Title of Class of Securities) 68247Q 102** (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| January 28, 2019 |
EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the shares of Class A ordinary shares, par value of $0. |
|
| January 22, 2019 |
Exhibit 4.3 111, INC. AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Deposit Agreement September 12, 2018 TABLE OF CONTENTS ARTICLE 1. DEFINITIONS 1 SECTION 1.1. American Depositary Shares 1 SECTION 1.2. Commission 2 SECTION 1.3. Company 2 SECTION 1.4. Custodian 2 SECTION 1.5. Delisting Event 2 SECTION 1.6. Deliver; Surrender 2 SECTION 1.7. Depos |
|
| January 22, 2019 |
As filed with the Securities and Exchange Commission on January 22, 2019 Registration No. |
|
| January 18, 2019 |
YI / 111, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2019 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) |
|
| January 18, 2019 |
111, Inc. Announces Management and Board Changes Exhibit 99.1 111, Inc. Announces Management and Board Changes SHANGHAI, China, Jan. 18, 2019 (GLOBE NEWSWIRE) — 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform in China, today announced that Mr. Weihao Xu has resigned as Chief Financial Officer and director for personal reasons. The Company has begun a process to appoint a successor to M |
|
| January 18, 2019 |
YI / 111, Inc. / Verlinvest Asia (hk) Ltd - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* 111, Inc. (Name of Issuer) Class A ordinary shares, par value $0.00005 per share (Title of Class of Securities) 68247Q102** (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| January 18, 2019 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned a |
|
| November 9, 2018 |
111, Inc. Announces Third Quarter 2018 Unaudited Financial Results Exhibit 99.1 111, Inc. Announces Third Quarter 2018 Unaudited Financial Results SHANGHAI, CHINA - November 8, 2018 - 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2018. Third Quarter 2018 Highlights · Net revenues were RMB497.6 million ( |
|
| November 9, 2018 |
YI / 111, Inc. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2018 Commission File Number: 001-38639 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People’s Republic of China (Address of principal executive offices) |
|
| September 13, 2018 |
7,175,000 American Depositary Shares 111, Inc. Representing 14,350,000 Class A Ordinary Shares Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents Filed Pursuant to Rule 424b(4) Registration No. |
|
| September 7, 2018 |
Form of Underwriting Agreement Exhibit 1.1 111, Inc. [?] American Depositary Shares Representing [?] Class A Ordinary Shares Underwriting Agreement [?], 2018 J.P. Morgan Securities LLC Citigroup Global Markets Inc. China International Capital Corporation Hong Kong Securities Limited As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 101 |
|
| September 7, 2018 |
QuickLinks - Click here to rapidly navigate through this document Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Registration No. |
|
| September 7, 2018 |
J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 China International Capital Corporation Hong Kong Securities Limited 29th Floor, One International Finance Centre 1 Harbour View Street, Central Hong Kong September 7, 2018 Securities and Exchange Commission Division of Corporation Finance 100 F Street, |
|
| September 7, 2018 |
September 7, 2018 VIA EDGAR Mr. John Reynolds Ms. Brigitte Lippman Mr. Jonathan Burr Mr. Blaise Rhodes Mr. Raj Rajan Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 U. S. A. Re: 111, Inc. (CIK No. 0001738906) Registration Statement on Form F-1 (File No. 333-226849) Registration Statement on Form 8-A (File No. 001-38639) Dear Ladies and G |
|
| September 7, 2018 |
As filed with the Securities and Exchange Commission on September 7, 2018 Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS As filed with the Securities and Exchange Commission on September 7, 2018 Registration No. |
|
| September 7, 2018 |
DIRECT DIAL AFFILIATE OFFICES (852) 3740-4863 SKADDEN, ARPS, SLATE, MEAGHER & FLOM DIRECT FAX 世達國際律師事務所 BOSTON (852) 3910-4863 42/F, EDINBURGH TOWER, THE LANDMARK CHICAGO EMAIL ADDRESS 15 QUEEN’S ROAD CENTRAL, HONG KONG HOUSTON JULIE. |
|
| August 29, 2018 |
Consent of Nee Chuan Teo, an independent director appointee Exhibit 99.4 August 29, 2018 111, Inc. (the ?Company?) 3-4/F, No.295 ZuChongZhi Road Pudong New Area, Shanghai 201203 People?s Republic of China +(86) 21 2053 6666 Ladies and Gentlemen: Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as a director of the Company, effective immediately upon the effectiveness of the Company?s registrati |
|
| August 29, 2018 |
Exhibit 10.6 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this ?Agreement?) is made as of , 2018 by and between 111, Inc., an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands (the ?Company?), and([Passport/ID] Number ) (the ?Indemnitee?). WHEREAS, the Indemnitee has agreed to serve as a director or executive officer of the Company |
|
| August 29, 2018 |
Exhibit 3.2 THE COMPANIES LAW (2018 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES TWELFTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF 111, INC. (adopted by a Special Resolution passed on August 21, 2018 and effective immediately prior to the completion of the initial public offering of the Company?s American Depositary Shares representing its Class A Ordinary Shares) 1. The name |
|
| August 29, 2018 |
Exhibit 10.4 111, INC. 2018 SHARE INCENTIVE PLAN ARTICLE 1 PURPOSE The purpose of this 2018 Share Incentive Plan (the ?Plan?) is to promote the success and enhance the value of 111, Inc., an exempted company formed under the laws of the Cayman Islands (the ?Company?), by linking the personal interests of the Directors, Employees, and Consultants to those of the Company?s shareholders and by provid |
|
| August 29, 2018 |
As filed with the Securities and Exchange Commission on August 29, 2018 Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents As filed with the Securities and Exchange Commission on August 29, 2018 Registration No. |
|
| August 29, 2018 |
Consent of Jun Luo, an independent director appointee Exhibit 99.6 August 29, 2018 111, Inc. (the ?Company?) 3-4/F, No.295 ZuChongZhi Road Pudong New Area, Shanghai 201203 People?s Republic of China +(86) 21 2053 6666 Ladies and Gentlemen: Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as a director of the Company, effective immediately upon the effectiveness of the Company?s registrati |
|
| August 29, 2018 |
Consent of Jian Sun, an independent director appointee Exhibit 99.5 August 29, 2018 111, Inc. (the ?Company?) 3-4/F, No.295 ZuChongZhi Road Pudong New Area, Shanghai 201203 People?s Republic of China +(86) 21 2053 6666 Ladies and Gentlemen: Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as a director of the Company, effective immediately upon the effectiveness of the Company?s registrati |
|
| August 29, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 111, Inc. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (State of incorporation or organization) (I.R.S. Employer Identification No.) 3-4/F, No.295 ZuChongZhi |
|
| August 29, 2018 |
Exhibit 99.1 111, INC. CODE OF BUSINESS CONDUCT AND ETHICS (Adopted by the Board of Directors of 111, Inc. on August 21, 2018, effective upon the effectiveness of its registration statement on Form F-1 relating to its initial public offering) I. PURPOSE This Code of Business Conduct and Ethics (the ?Code?) contains general guidelines for conducting the business of 111, Inc. and its subsidiaries an |
|
| August 29, 2018 |
Exhibit 4.2 111, Inc. NAME AND ADDRESS CERTIFICATE NUMBER DISTINCTIVE NUMBERS PAR VALUE PER SHARE OF SHAREHOLDER FROM TO DATE OF ISSUE NO. OF SHARES CONSIDERATION PAID Class A Ordinary Shares SHARE CERTIFICATE OF 111, Inc. INCORPORATED IN THE CAYMAN ISLANDS The authorised share capital of the Company is US$50,000.00 divided into 1,000,000,000 shares comprising (i) 800,000,000 Class A Ordinary Shar |
|
| August 29, 2018 |
SKADDEN, ARPS, SLATE, MEAGHER & FLOM PARTNERS 世達國際律師事務所 AFFILIATE OFFICES CHRISTOPHER W. |
|
| August 29, 2018 |
Exhibit 10.5 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the ?Agreement?) is entered into as of , 20 by and between 111, Inc., an exempted company incorporated and existing under the laws of the Cayman Islands (the ?Company?) and , an individual with [passport/ID number] (the ?Executive?). RECITALS WHEREAS, the Company desires to employ the Executive and to assure itself of the services of the |
|
| August 29, 2018 |
Exhibit 4.3 111, INC. AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Deposit Agreement , 2018 TABLE OF CONTENTS ARTICLE 1. DEFINITIONS 1 SECTION 1.1. American Depositary Shares 1 SECTION 1.2. Commission 2 SECTION 1.3. Company 2 SECTION 1.4. Custodian 2 SECTION 1.5. Delisting Event 2 SECTION 1.6. Deliver; Surrender 2 SECTION 1.7. Deposit Agreement |
|
| August 15, 2018 |
Exhibit 10.15 Equity Pledge Agreement Regarding GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO., LTD. by and between YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. and GUANGDONG YIHAO PHARMACY CO., LTD. Date: September 5, 2013 This Equity Pledge Agreement (this ?Agreement?) is made in Shanghai, the People?s Republic of China (?PRC?) as of September 5, 2013 by and between: YAO FANG INFORMATION TECHN |
|
| August 15, 2018 |
Exhibit 10.22 Shanghai Zhangjiang Hi-tech Park Property Lease/Pre-lease Contract (Version 2016) [ ] Property Lease/Pre-lease Contract Contract No.: Place of Execution: Landlord: Shanghai Zhangjiang Hi-tech Park Development Co., Ltd. (hereinafter referred to as ?Party A?) Tenant: Yao Fang Information Technology (Shanghai) Co., Ltd. (hereinafter referred to as ?Party B?) In accordance with the Contr |
|
| August 15, 2018 |
Exhibit 10.16 YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. And GUANGDONG YIHAO PHARMACY CO., LTD. Regarding GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO., LTD. Exclusive Option Agreement September 5, 2013 1 This Exclusive Option Agreement (?Agreement?) was made and entered into on September 5, 2013 by and among the following parties in Shanghai, the People?s Republic of China (?China?): YAO FAN |
|
| August 15, 2018 |
Exhibit 10.19 Equity Pledge Agreement Regarding SHANGHAI YAOWANG E-COMMERCE CO., LTD. by and between YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. And GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO., LTD. Date: September 5, 2013 This Equity Pledge Agreement (this ?Agreement?) is made in Shanghai, the People?s Republic of China (?PRC?) as of September 5, 2013 by and between: YAO FANG INFORMATION TE |
|
| August 15, 2018 |
Exhibit 21.1 Principal Subsidiaries, Consolidated Affiliated Entities and Subsidiaries of Consolidated Affiliated Entities of the Registrant Subsidiaries: Yao Wang Corporation Limited, a Hong Kong company Yao Fang Information Technology (Shanghai) Co., Ltd., a PRC company Wuhan Central China Drug Trading Co., Ltd., a PRC company Consolidated Affiliated Entities: Guangdong Yihao Pharmacy Co., Ltd., |
|
| August 15, 2018 |
Exhibit 10.17 Exclusive Support Services Agreement Between SHANGHAI YAOWANG E-COMMERCE CO., LTD. And YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. September 5, 2013 This Exclusive Support Services Agreement (the ?Agreement?) is concluded and signed on September 5, 2013 in Shanghai, the People?s Republic of China (?China?) by and between: SHANGHAI YAOWANG E-COMMERCE CO., LTD. (the ?Operator? |
|
| August 15, 2018 |
Exhibit 10.9 YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. And Shuhong YUAN Yue XUAN Regarding GUANGDONG YIHAO PHARMACY CO., LTD. Exclusive Option Agreement September 5, 2013 1 This Exclusive Option Agreement (?Agreement?) was made and entered into on September 5, 2013 by and among the following parties in Shanghai, the People?s Republic of China (?China?): YAO FANG INFORMATION TECHNOLOGY ( |
|
| August 15, 2018 |
Exhibit 10.2 2014 ESOP Policy Basic Principles Each stock option grant shall become effective only after the grant is approved by the Board of the Company. The employees who are to receive the stock options shall sign relevant legal documents with the Company to become stock option grantees. The signatories shall be employees of the Company when signing the relevant legal documents. The Company gr |
|
| August 15, 2018 |
Exhibit 10.1 ESOP Policy (2013) Basic Principles Each stock option grant shall become effective only after the grant is approved by the Board of the Company. The employees who are to receive the stock options shall sign relevant legal documents with the Company to become stock option grantees. The signatories shall be employees of the Company when signing the relevant legal documents. The Company |
|
| August 15, 2018 |
Exhibit 10.12 Equity Pledge Agreement regarding GUANGDONG YIHAO PHARMACY CO., LTD. by and between YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. and Jing LIU and Yue XUAN Date: July 13, 2017 This Equity Pledge Agreement (this ?Agreement?) was made in Shanghai, the People?s Republic of China (?PRC?) on July 13, 2017 by and between: YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD., a wholl |
|
| August 15, 2018 |
Exhibit 10.18 YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. And GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO., LTD. Regarding SHANGHAI YAOWANG E-COMMERCE CO., LTD. Exclusive Option Agreement September 5, 2013 1 This Exclusive Option Agreement (?Agreement?) was made and entered into on September 5, 2013 by and among the following parties in Shanghai, the People?s Republic of China (?China?): YAO |
|
| August 15, 2018 |
Exhibit 3.1 Company No.: 278041 THE COMPANIES LAW (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES ELEVENTH AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF 111, Inc. (adopted by a special resolution passed on June 19, 2018) 1. The name of the Company is 111, Inc. 2. The registered office of the Company shall be at the offices of Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, |
|
| August 15, 2018 |
Consent of Frost & Sullivan (Beijing) Inc., Shanghai Branch Co. Exhibit 99.3 June 26, 2018 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of China Re: Consent of Frost & Sullivan (Beijing) Inc., Shanghai Branch Co. We hereby consent to (1) the use of and references to our name and the inclusion of information, data and statements from our research reports and amendments thereto, (i) in the prospectus included in |
|
| August 15, 2018 |
Exhibit 99.2 ? ? ? ? ? ? ? Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel: (8610) 65693399 Fax: (8610) 65693838, 65693836, 65693837, 65693839 E-mail Add: [email protected] Website: www.tongshang.com.cn August 15, 2018 111, Inc. 3-4/F, No.295 ZuChongZhi Road, Pudong New Area Shanghai, 201203 The People?s Republic of C |
|
| August 15, 2018 |
Exhibit 10.20 GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO., LTD. YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. And SHANGHAI YAOWANG E-COMMERCE CO., LTD. PROXY AGREEMENT September 5, 2013 1 This PROXY AGREEMENT (?Agreement?) is made and entered into on September 5,2013 by and among the following parties in Shanghai, the People?s Republic of China (?China?): GUANGDONG YIHAO PHARMACEUTICAL CHAIN C |
|
| August 15, 2018 |
Exhibit 10.11 Rights and Obligations Assignment Agreement This Rights and Obligations Assignment Agreement (this ?Agreement?) is made in Shanghai as of July 13, 2017 by and among: (1) Jing LIU, a citizen of the People?s Republic of China (?PRC?) whose ID number is ******************; (2) Shuhong YUAN, Chinese Citizen, ID No.: ******************; (3) Yue XUAN, Chinese Citizen, ID No.: ************* |
|
| August 15, 2018 |
Power of Attorney (included on signature page) Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents As filed with the Securities and Exchange Commission on August 15, 2018 Registration No. |
|
| August 15, 2018 |
Exhibit 4.4 TENTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT by and among 111, INC. GANG YU JUNLING LIU SUNNY BAY GLOBAL LIMITED IVY CAPITAL 2011 HOLDCO LTD. GOLD STAND GOAL LIMITED CLEARVUE YW HOLDINGS, LTD. VERLINVEST ASIA (HK) LIMITED FIRST PHARMACIA INTERNATIONAL RICH CHANCE GLOBAL LIMITED ZALL CAPITAL LIMITED VERLINVEST ASIA (HK) LIMITED ALLIED CHINA INVESTMENT LIMITED TONGYI INVESTMENT HOLD |
|
| August 15, 2018 |
Exhibit 10.10 Equity Transfer Agreement This Equity Transfer Agreement (this ?Agreement?) is made as of July 13, 2017 by and among: (1) Jing LIU, a citizen of the People?s Republic of China (?PRC?) whose ID number is ****************** (?Buyer?); (2) Shuhong YUAN, a PRC citizen whose ID number is ****************** (?Seller?); and (3) Yue XUAN, a PRC citizen whose ID number is ****************** ( |
